Global Hospital-Acquired Disease Testing Market Research Report 2024(Status and Outlook)
Report Overview:
Hospital acquired infections/diseases (HAIs) or nosocomial infections are defined to the infection acquired by patients during their stay in healthcare settings. Approximately 9.2 out of 100 patients in the U.S. acquire HAI. The most common types of HAIs include pneumonia, urinary tract infection, bloodstream infection, surgical site infection and others. HAIs are caused by pathogens among patients with compromised immune system, and negligence by hospital staff. The significant morbidity and mortality, the associated management costs and growing pressure from governing bodies have urged care-givers to devise accurate diagnosis of HAIs for efficient healthcare provision.
The Global Hospital-Acquired Disease Testing Market Size was estimated at USD 522.01 million in 2023 and is projected to reach USD 707.58 million by 2029, exhibiting a CAGR of 5.20% during the forecast period.
This report provides a deep insight into the global Hospital-Acquired Disease Testing market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Hospital-Acquired Disease Testing Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Hospital-Acquired Disease Testing market in any manner.
Global Hospital-Acquired Disease Testing Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Diatherix Laboratories
Gen-Probe
Qiagen
F. Hoffmann-La Roche
Cepheid
Life Technologies Corporation
Meridian Biosciences
Cantel Medical Corporation
Nordion
Market Segmentation (by Type)
UTI Testing
SSI Testing
Pneumococcal Infections Testing
Bloodstream Infections Testing
MRSA Testing
Market Segmentation (by Application)
Small and Medium Sized Hospitals
Large Sized Hospitals
Geographic Segmentation
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Note: this report may need to undergo a final check or review and this could take about 48 hours.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Hospital-Acquired Disease Testing Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the Market's Competitive Landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
Hospital acquired infections/diseases (HAIs) or nosocomial infections are defined to the infection acquired by patients during their stay in healthcare settings. Approximately 9.2 out of 100 patients in the U.S. acquire HAI. The most common types of HAIs include pneumonia, urinary tract infection, bloodstream infection, surgical site infection and others. HAIs are caused by pathogens among patients with compromised immune system, and negligence by hospital staff. The significant morbidity and mortality, the associated management costs and growing pressure from governing bodies have urged care-givers to devise accurate diagnosis of HAIs for efficient healthcare provision.
The Global Hospital-Acquired Disease Testing Market Size was estimated at USD 522.01 million in 2023 and is projected to reach USD 707.58 million by 2029, exhibiting a CAGR of 5.20% during the forecast period.
This report provides a deep insight into the global Hospital-Acquired Disease Testing market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Hospital-Acquired Disease Testing Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Hospital-Acquired Disease Testing market in any manner.
Global Hospital-Acquired Disease Testing Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Diatherix Laboratories
Gen-Probe
Qiagen
F. Hoffmann-La Roche
Cepheid
Life Technologies Corporation
Meridian Biosciences
Cantel Medical Corporation
Nordion
Market Segmentation (by Type)
UTI Testing
SSI Testing
Pneumococcal Infections Testing
Bloodstream Infections Testing
MRSA Testing
Market Segmentation (by Application)
Small and Medium Sized Hospitals
Large Sized Hospitals
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the Hospital-Acquired Disease Testing Market
- Overview of the regional outlook of the Hospital-Acquired Disease Testing Market:
- Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
- This enables you to anticipate market changes to remain ahead of your competitors
- You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
- The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
- Provision of market value (USD Billion) data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- 6-month post-sales analyst support
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Note: this report may need to undergo a final check or review and this could take about 48 hours.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Hospital-Acquired Disease Testing Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the Market's Competitive Landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Hospital-Acquired Disease Testing
1.2 Key Market Segments
1.2.1 Hospital-Acquired Disease Testing Segment by Type
1.2.2 Hospital-Acquired Disease Testing Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 HOSPITAL-ACQUIRED DISEASE TESTING MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Hospital-Acquired Disease Testing Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Hospital-Acquired Disease Testing Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 HOSPITAL-ACQUIRED DISEASE TESTING MARKET COMPETITIVE LANDSCAPE
3.1 Global Hospital-Acquired Disease Testing Sales by Manufacturers (2019-2024)
3.2 Global Hospital-Acquired Disease Testing Revenue Market Share by Manufacturers (2019-2024)
3.3 Hospital-Acquired Disease Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Hospital-Acquired Disease Testing Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Hospital-Acquired Disease Testing Sales Sites, Area Served, Product Type
3.6 Hospital-Acquired Disease Testing Market Competitive Situation and Trends
3.6.1 Hospital-Acquired Disease Testing Market Concentration Rate
3.6.2 Global 5 and 10 Largest Hospital-Acquired Disease Testing Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 HOSPITAL-ACQUIRED DISEASE TESTING INDUSTRY CHAIN ANALYSIS
4.1 Hospital-Acquired Disease Testing Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF HOSPITAL-ACQUIRED DISEASE TESTING MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 HOSPITAL-ACQUIRED DISEASE TESTING MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Hospital-Acquired Disease Testing Sales Market Share by Type (2019-2024)
6.3 Global Hospital-Acquired Disease Testing Market Size Market Share by Type (2019-2024)
6.4 Global Hospital-Acquired Disease Testing Price by Type (2019-2024)
7 HOSPITAL-ACQUIRED DISEASE TESTING MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Hospital-Acquired Disease Testing Market Sales by Application (2019-2024)
7.3 Global Hospital-Acquired Disease Testing Market Size (M USD) by Application (2019-2024)
7.4 Global Hospital-Acquired Disease Testing Sales Growth Rate by Application (2019-2024)
8 HOSPITAL-ACQUIRED DISEASE TESTING MARKET SEGMENTATION BY REGION
8.1 Global Hospital-Acquired Disease Testing Sales by Region
8.1.1 Global Hospital-Acquired Disease Testing Sales by Region
8.1.2 Global Hospital-Acquired Disease Testing Sales Market Share by Region
8.2 North America
8.2.1 North America Hospital-Acquired Disease Testing Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Hospital-Acquired Disease Testing Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Hospital-Acquired Disease Testing Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Hospital-Acquired Disease Testing Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Hospital-Acquired Disease Testing Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 Diatherix Laboratories
9.1.1 Diatherix Laboratories Hospital-Acquired Disease Testing Basic Information
9.1.2 Diatherix Laboratories Hospital-Acquired Disease Testing Product Overview
9.1.3 Diatherix Laboratories Hospital-Acquired Disease Testing Product Market Performance
9.1.4 Diatherix Laboratories Business Overview
9.1.5 Diatherix Laboratories Hospital-Acquired Disease Testing SWOT Analysis
9.1.6 Diatherix Laboratories Recent Developments
9.2 Gen-Probe
9.2.1 Gen-Probe Hospital-Acquired Disease Testing Basic Information
9.2.2 Gen-Probe Hospital-Acquired Disease Testing Product Overview
9.2.3 Gen-Probe Hospital-Acquired Disease Testing Product Market Performance
9.2.4 Gen-Probe Business Overview
9.2.5 Gen-Probe Hospital-Acquired Disease Testing SWOT Analysis
9.2.6 Gen-Probe Recent Developments
9.3 Qiagen
9.3.1 Qiagen Hospital-Acquired Disease Testing Basic Information
9.3.2 Qiagen Hospital-Acquired Disease Testing Product Overview
9.3.3 Qiagen Hospital-Acquired Disease Testing Product Market Performance
9.3.4 Qiagen Hospital-Acquired Disease Testing SWOT Analysis
9.3.5 Qiagen Business Overview
9.3.6 Qiagen Recent Developments
9.4 F. Hoffmann-La Roche
9.4.1 F. Hoffmann-La Roche Hospital-Acquired Disease Testing Basic Information
9.4.2 F. Hoffmann-La Roche Hospital-Acquired Disease Testing Product Overview
9.4.3 F. Hoffmann-La Roche Hospital-Acquired Disease Testing Product Market Performance
9.4.4 F. Hoffmann-La Roche Business Overview
9.4.5 F. Hoffmann-La Roche Recent Developments
9.5 Cepheid
9.5.1 Cepheid Hospital-Acquired Disease Testing Basic Information
9.5.2 Cepheid Hospital-Acquired Disease Testing Product Overview
9.5.3 Cepheid Hospital-Acquired Disease Testing Product Market Performance
9.5.4 Cepheid Business Overview
9.5.5 Cepheid Recent Developments
9.6 Life Technologies Corporation
9.6.1 Life Technologies Corporation Hospital-Acquired Disease Testing Basic Information
9.6.2 Life Technologies Corporation Hospital-Acquired Disease Testing Product Overview
9.6.3 Life Technologies Corporation Hospital-Acquired Disease Testing Product Market Performance
9.6.4 Life Technologies Corporation Business Overview
9.6.5 Life Technologies Corporation Recent Developments
9.7 Meridian Biosciences
9.7.1 Meridian Biosciences Hospital-Acquired Disease Testing Basic Information
9.7.2 Meridian Biosciences Hospital-Acquired Disease Testing Product Overview
9.7.3 Meridian Biosciences Hospital-Acquired Disease Testing Product Market Performance
9.7.4 Meridian Biosciences Business Overview
9.7.5 Meridian Biosciences Recent Developments
9.8 Cantel Medical Corporation
9.8.1 Cantel Medical Corporation Hospital-Acquired Disease Testing Basic Information
9.8.2 Cantel Medical Corporation Hospital-Acquired Disease Testing Product Overview
9.8.3 Cantel Medical Corporation Hospital-Acquired Disease Testing Product Market Performance
9.8.4 Cantel Medical Corporation Business Overview
9.8.5 Cantel Medical Corporation Recent Developments
9.9 Nordion
9.9.1 Nordion Hospital-Acquired Disease Testing Basic Information
9.9.2 Nordion Hospital-Acquired Disease Testing Product Overview
9.9.3 Nordion Hospital-Acquired Disease Testing Product Market Performance
9.9.4 Nordion Business Overview
9.9.5 Nordion Recent Developments
10 HOSPITAL-ACQUIRED DISEASE TESTING MARKET FORECAST BY REGION
10.1 Global Hospital-Acquired Disease Testing Market Size Forecast
10.2 Global Hospital-Acquired Disease Testing Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Hospital-Acquired Disease Testing Market Size Forecast by Country
10.2.3 Asia Pacific Hospital-Acquired Disease Testing Market Size Forecast by Region
10.2.4 South America Hospital-Acquired Disease Testing Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Hospital-Acquired Disease Testing by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global Hospital-Acquired Disease Testing Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Hospital-Acquired Disease Testing by Type (2025-2030)
11.1.2 Global Hospital-Acquired Disease Testing Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Hospital-Acquired Disease Testing by Type (2025-2030)
11.2 Global Hospital-Acquired Disease Testing Market Forecast by Application (2025-2030)
11.2.1 Global Hospital-Acquired Disease Testing Sales (K Units) Forecast by Application
11.2.2 Global Hospital-Acquired Disease Testing Market Size (M USD) Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Hospital-Acquired Disease Testing
1.2 Key Market Segments
1.2.1 Hospital-Acquired Disease Testing Segment by Type
1.2.2 Hospital-Acquired Disease Testing Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 HOSPITAL-ACQUIRED DISEASE TESTING MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Hospital-Acquired Disease Testing Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Hospital-Acquired Disease Testing Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 HOSPITAL-ACQUIRED DISEASE TESTING MARKET COMPETITIVE LANDSCAPE
3.1 Global Hospital-Acquired Disease Testing Sales by Manufacturers (2019-2024)
3.2 Global Hospital-Acquired Disease Testing Revenue Market Share by Manufacturers (2019-2024)
3.3 Hospital-Acquired Disease Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Hospital-Acquired Disease Testing Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Hospital-Acquired Disease Testing Sales Sites, Area Served, Product Type
3.6 Hospital-Acquired Disease Testing Market Competitive Situation and Trends
3.6.1 Hospital-Acquired Disease Testing Market Concentration Rate
3.6.2 Global 5 and 10 Largest Hospital-Acquired Disease Testing Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 HOSPITAL-ACQUIRED DISEASE TESTING INDUSTRY CHAIN ANALYSIS
4.1 Hospital-Acquired Disease Testing Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF HOSPITAL-ACQUIRED DISEASE TESTING MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 HOSPITAL-ACQUIRED DISEASE TESTING MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Hospital-Acquired Disease Testing Sales Market Share by Type (2019-2024)
6.3 Global Hospital-Acquired Disease Testing Market Size Market Share by Type (2019-2024)
6.4 Global Hospital-Acquired Disease Testing Price by Type (2019-2024)
7 HOSPITAL-ACQUIRED DISEASE TESTING MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Hospital-Acquired Disease Testing Market Sales by Application (2019-2024)
7.3 Global Hospital-Acquired Disease Testing Market Size (M USD) by Application (2019-2024)
7.4 Global Hospital-Acquired Disease Testing Sales Growth Rate by Application (2019-2024)
8 HOSPITAL-ACQUIRED DISEASE TESTING MARKET SEGMENTATION BY REGION
8.1 Global Hospital-Acquired Disease Testing Sales by Region
8.1.1 Global Hospital-Acquired Disease Testing Sales by Region
8.1.2 Global Hospital-Acquired Disease Testing Sales Market Share by Region
8.2 North America
8.2.1 North America Hospital-Acquired Disease Testing Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Hospital-Acquired Disease Testing Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Hospital-Acquired Disease Testing Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Hospital-Acquired Disease Testing Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Hospital-Acquired Disease Testing Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 Diatherix Laboratories
9.1.1 Diatherix Laboratories Hospital-Acquired Disease Testing Basic Information
9.1.2 Diatherix Laboratories Hospital-Acquired Disease Testing Product Overview
9.1.3 Diatherix Laboratories Hospital-Acquired Disease Testing Product Market Performance
9.1.4 Diatherix Laboratories Business Overview
9.1.5 Diatherix Laboratories Hospital-Acquired Disease Testing SWOT Analysis
9.1.6 Diatherix Laboratories Recent Developments
9.2 Gen-Probe
9.2.1 Gen-Probe Hospital-Acquired Disease Testing Basic Information
9.2.2 Gen-Probe Hospital-Acquired Disease Testing Product Overview
9.2.3 Gen-Probe Hospital-Acquired Disease Testing Product Market Performance
9.2.4 Gen-Probe Business Overview
9.2.5 Gen-Probe Hospital-Acquired Disease Testing SWOT Analysis
9.2.6 Gen-Probe Recent Developments
9.3 Qiagen
9.3.1 Qiagen Hospital-Acquired Disease Testing Basic Information
9.3.2 Qiagen Hospital-Acquired Disease Testing Product Overview
9.3.3 Qiagen Hospital-Acquired Disease Testing Product Market Performance
9.3.4 Qiagen Hospital-Acquired Disease Testing SWOT Analysis
9.3.5 Qiagen Business Overview
9.3.6 Qiagen Recent Developments
9.4 F. Hoffmann-La Roche
9.4.1 F. Hoffmann-La Roche Hospital-Acquired Disease Testing Basic Information
9.4.2 F. Hoffmann-La Roche Hospital-Acquired Disease Testing Product Overview
9.4.3 F. Hoffmann-La Roche Hospital-Acquired Disease Testing Product Market Performance
9.4.4 F. Hoffmann-La Roche Business Overview
9.4.5 F. Hoffmann-La Roche Recent Developments
9.5 Cepheid
9.5.1 Cepheid Hospital-Acquired Disease Testing Basic Information
9.5.2 Cepheid Hospital-Acquired Disease Testing Product Overview
9.5.3 Cepheid Hospital-Acquired Disease Testing Product Market Performance
9.5.4 Cepheid Business Overview
9.5.5 Cepheid Recent Developments
9.6 Life Technologies Corporation
9.6.1 Life Technologies Corporation Hospital-Acquired Disease Testing Basic Information
9.6.2 Life Technologies Corporation Hospital-Acquired Disease Testing Product Overview
9.6.3 Life Technologies Corporation Hospital-Acquired Disease Testing Product Market Performance
9.6.4 Life Technologies Corporation Business Overview
9.6.5 Life Technologies Corporation Recent Developments
9.7 Meridian Biosciences
9.7.1 Meridian Biosciences Hospital-Acquired Disease Testing Basic Information
9.7.2 Meridian Biosciences Hospital-Acquired Disease Testing Product Overview
9.7.3 Meridian Biosciences Hospital-Acquired Disease Testing Product Market Performance
9.7.4 Meridian Biosciences Business Overview
9.7.5 Meridian Biosciences Recent Developments
9.8 Cantel Medical Corporation
9.8.1 Cantel Medical Corporation Hospital-Acquired Disease Testing Basic Information
9.8.2 Cantel Medical Corporation Hospital-Acquired Disease Testing Product Overview
9.8.3 Cantel Medical Corporation Hospital-Acquired Disease Testing Product Market Performance
9.8.4 Cantel Medical Corporation Business Overview
9.8.5 Cantel Medical Corporation Recent Developments
9.9 Nordion
9.9.1 Nordion Hospital-Acquired Disease Testing Basic Information
9.9.2 Nordion Hospital-Acquired Disease Testing Product Overview
9.9.3 Nordion Hospital-Acquired Disease Testing Product Market Performance
9.9.4 Nordion Business Overview
9.9.5 Nordion Recent Developments
10 HOSPITAL-ACQUIRED DISEASE TESTING MARKET FORECAST BY REGION
10.1 Global Hospital-Acquired Disease Testing Market Size Forecast
10.2 Global Hospital-Acquired Disease Testing Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Hospital-Acquired Disease Testing Market Size Forecast by Country
10.2.3 Asia Pacific Hospital-Acquired Disease Testing Market Size Forecast by Region
10.2.4 South America Hospital-Acquired Disease Testing Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Hospital-Acquired Disease Testing by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global Hospital-Acquired Disease Testing Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Hospital-Acquired Disease Testing by Type (2025-2030)
11.1.2 Global Hospital-Acquired Disease Testing Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Hospital-Acquired Disease Testing by Type (2025-2030)
11.2 Global Hospital-Acquired Disease Testing Market Forecast by Application (2025-2030)
11.2.1 Global Hospital-Acquired Disease Testing Sales (K Units) Forecast by Application
11.2.2 Global Hospital-Acquired Disease Testing Market Size (M USD) Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Hospital-Acquired Disease Testing Market Size Comparison by Region (M USD)
Table 5. Global Hospital-Acquired Disease Testing Sales (K Units) by Manufacturers (2019-2024)
Table 6. Global Hospital-Acquired Disease Testing Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Hospital-Acquired Disease Testing Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Hospital-Acquired Disease Testing Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hospital-Acquired Disease Testing as of 2022)
Table 10. Global Market Hospital-Acquired Disease Testing Average Price (USD/Unit) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Hospital-Acquired Disease Testing Sales Sites and Area Served
Table 12. Manufacturers Hospital-Acquired Disease Testing Product Type
Table 13. Global Hospital-Acquired Disease Testing Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Hospital-Acquired Disease Testing
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Hospital-Acquired Disease Testing Market Challenges
Table 22. Global Hospital-Acquired Disease Testing Sales by Type (K Units)
Table 23. Global Hospital-Acquired Disease Testing Market Size by Type (M USD)
Table 24. Global Hospital-Acquired Disease Testing Sales (K Units) by Type (2019-2024)
Table 25. Global Hospital-Acquired Disease Testing Sales Market Share by Type (2019-2024)
Table 26. Global Hospital-Acquired Disease Testing Market Size (M USD) by Type (2019-2024)
Table 27. Global Hospital-Acquired Disease Testing Market Size Share by Type (2019-2024)
Table 28. Global Hospital-Acquired Disease Testing Price (USD/Unit) by Type (2019-2024)
Table 29. Global Hospital-Acquired Disease Testing Sales (K Units) by Application
Table 30. Global Hospital-Acquired Disease Testing Market Size by Application
Table 31. Global Hospital-Acquired Disease Testing Sales by Application (2019-2024) & (K Units)
Table 32. Global Hospital-Acquired Disease Testing Sales Market Share by Application (2019-2024)
Table 33. Global Hospital-Acquired Disease Testing Sales by Application (2019-2024) & (M USD)
Table 34. Global Hospital-Acquired Disease Testing Market Share by Application (2019-2024)
Table 35. Global Hospital-Acquired Disease Testing Sales Growth Rate by Application (2019-2024)
Table 36. Global Hospital-Acquired Disease Testing Sales by Region (2019-2024) & (K Units)
Table 37. Global Hospital-Acquired Disease Testing Sales Market Share by Region (2019-2024)
Table 38. North America Hospital-Acquired Disease Testing Sales by Country (2019-2024) & (K Units)
Table 39. Europe Hospital-Acquired Disease Testing Sales by Country (2019-2024) & (K Units)
Table 40. Asia Pacific Hospital-Acquired Disease Testing Sales by Region (2019-2024) & (K Units)
Table 41. South America Hospital-Acquired Disease Testing Sales by Country (2019-2024) & (K Units)
Table 42. Middle East and Africa Hospital-Acquired Disease Testing Sales by Region (2019-2024) & (K Units)
Table 43. Diatherix Laboratories Hospital-Acquired Disease Testing Basic Information
Table 44. Diatherix Laboratories Hospital-Acquired Disease Testing Product Overview
Table 45. Diatherix Laboratories Hospital-Acquired Disease Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 46. Diatherix Laboratories Business Overview
Table 47. Diatherix Laboratories Hospital-Acquired Disease Testing SWOT Analysis
Table 48. Diatherix Laboratories Recent Developments
Table 49. Gen-Probe Hospital-Acquired Disease Testing Basic Information
Table 50. Gen-Probe Hospital-Acquired Disease Testing Product Overview
Table 51. Gen-Probe Hospital-Acquired Disease Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 52. Gen-Probe Business Overview
Table 53. Gen-Probe Hospital-Acquired Disease Testing SWOT Analysis
Table 54. Gen-Probe Recent Developments
Table 55. Qiagen Hospital-Acquired Disease Testing Basic Information
Table 56. Qiagen Hospital-Acquired Disease Testing Product Overview
Table 57. Qiagen Hospital-Acquired Disease Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 58. Qiagen Hospital-Acquired Disease Testing SWOT Analysis
Table 59. Qiagen Business Overview
Table 60. Qiagen Recent Developments
Table 61. F. Hoffmann-La Roche Hospital-Acquired Disease Testing Basic Information
Table 62. F. Hoffmann-La Roche Hospital-Acquired Disease Testing Product Overview
Table 63. F. Hoffmann-La Roche Hospital-Acquired Disease Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 64. F. Hoffmann-La Roche Business Overview
Table 65. F. Hoffmann-La Roche Recent Developments
Table 66. Cepheid Hospital-Acquired Disease Testing Basic Information
Table 67. Cepheid Hospital-Acquired Disease Testing Product Overview
Table 68. Cepheid Hospital-Acquired Disease Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 69. Cepheid Business Overview
Table 70. Cepheid Recent Developments
Table 71. Life Technologies Corporation Hospital-Acquired Disease Testing Basic Information
Table 72. Life Technologies Corporation Hospital-Acquired Disease Testing Product Overview
Table 73. Life Technologies Corporation Hospital-Acquired Disease Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 74. Life Technologies Corporation Business Overview
Table 75. Life Technologies Corporation Recent Developments
Table 76. Meridian Biosciences Hospital-Acquired Disease Testing Basic Information
Table 77. Meridian Biosciences Hospital-Acquired Disease Testing Product Overview
Table 78. Meridian Biosciences Hospital-Acquired Disease Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 79. Meridian Biosciences Business Overview
Table 80. Meridian Biosciences Recent Developments
Table 81. Cantel Medical Corporation Hospital-Acquired Disease Testing Basic Information
Table 82. Cantel Medical Corporation Hospital-Acquired Disease Testing Product Overview
Table 83. Cantel Medical Corporation Hospital-Acquired Disease Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 84. Cantel Medical Corporation Business Overview
Table 85. Cantel Medical Corporation Recent Developments
Table 86. Nordion Hospital-Acquired Disease Testing Basic Information
Table 87. Nordion Hospital-Acquired Disease Testing Product Overview
Table 88. Nordion Hospital-Acquired Disease Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 89. Nordion Business Overview
Table 90. Nordion Recent Developments
Table 91. Global Hospital-Acquired Disease Testing Sales Forecast by Region (2025-2030) & (K Units)
Table 92. Global Hospital-Acquired Disease Testing Market Size Forecast by Region (2025-2030) & (M USD)
Table 93. North America Hospital-Acquired Disease Testing Sales Forecast by Country (2025-2030) & (K Units)
Table 94. North America Hospital-Acquired Disease Testing Market Size Forecast by Country (2025-2030) & (M USD)
Table 95. Europe Hospital-Acquired Disease Testing Sales Forecast by Country (2025-2030) & (K Units)
Table 96. Europe Hospital-Acquired Disease Testing Market Size Forecast by Country (2025-2030) & (M USD)
Table 97. Asia Pacific Hospital-Acquired Disease Testing Sales Forecast by Region (2025-2030) & (K Units)
Table 98. Asia Pacific Hospital-Acquired Disease Testing Market Size Forecast by Region (2025-2030) & (M USD)
Table 99. South America Hospital-Acquired Disease Testing Sales Forecast by Country (2025-2030) & (K Units)
Table 100. South America Hospital-Acquired Disease Testing Market Size Forecast by Country (2025-2030) & (M USD)
Table 101. Middle East and Africa Hospital-Acquired Disease Testing Consumption Forecast by Country (2025-2030) & (Units)
Table 102. Middle East and Africa Hospital-Acquired Disease Testing Market Size Forecast by Country (2025-2030) & (M USD)
Table 103. Global Hospital-Acquired Disease Testing Sales Forecast by Type (2025-2030) & (K Units)
Table 104. Global Hospital-Acquired Disease Testing Market Size Forecast by Type (2025-2030) & (M USD)
Table 105. Global Hospital-Acquired Disease Testing Price Forecast by Type (2025-2030) & (USD/Unit)
Table 106. Global Hospital-Acquired Disease Testing Sales (K Units) Forecast by Application (2025-2030)
Table 107. Global Hospital-Acquired Disease Testing Market Size Forecast by Application (2025-2030) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Hospital-Acquired Disease Testing Market Size Comparison by Region (M USD)
Table 5. Global Hospital-Acquired Disease Testing Sales (K Units) by Manufacturers (2019-2024)
Table 6. Global Hospital-Acquired Disease Testing Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Hospital-Acquired Disease Testing Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Hospital-Acquired Disease Testing Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hospital-Acquired Disease Testing as of 2022)
Table 10. Global Market Hospital-Acquired Disease Testing Average Price (USD/Unit) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Hospital-Acquired Disease Testing Sales Sites and Area Served
Table 12. Manufacturers Hospital-Acquired Disease Testing Product Type
Table 13. Global Hospital-Acquired Disease Testing Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Hospital-Acquired Disease Testing
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Hospital-Acquired Disease Testing Market Challenges
Table 22. Global Hospital-Acquired Disease Testing Sales by Type (K Units)
Table 23. Global Hospital-Acquired Disease Testing Market Size by Type (M USD)
Table 24. Global Hospital-Acquired Disease Testing Sales (K Units) by Type (2019-2024)
Table 25. Global Hospital-Acquired Disease Testing Sales Market Share by Type (2019-2024)
Table 26. Global Hospital-Acquired Disease Testing Market Size (M USD) by Type (2019-2024)
Table 27. Global Hospital-Acquired Disease Testing Market Size Share by Type (2019-2024)
Table 28. Global Hospital-Acquired Disease Testing Price (USD/Unit) by Type (2019-2024)
Table 29. Global Hospital-Acquired Disease Testing Sales (K Units) by Application
Table 30. Global Hospital-Acquired Disease Testing Market Size by Application
Table 31. Global Hospital-Acquired Disease Testing Sales by Application (2019-2024) & (K Units)
Table 32. Global Hospital-Acquired Disease Testing Sales Market Share by Application (2019-2024)
Table 33. Global Hospital-Acquired Disease Testing Sales by Application (2019-2024) & (M USD)
Table 34. Global Hospital-Acquired Disease Testing Market Share by Application (2019-2024)
Table 35. Global Hospital-Acquired Disease Testing Sales Growth Rate by Application (2019-2024)
Table 36. Global Hospital-Acquired Disease Testing Sales by Region (2019-2024) & (K Units)
Table 37. Global Hospital-Acquired Disease Testing Sales Market Share by Region (2019-2024)
Table 38. North America Hospital-Acquired Disease Testing Sales by Country (2019-2024) & (K Units)
Table 39. Europe Hospital-Acquired Disease Testing Sales by Country (2019-2024) & (K Units)
Table 40. Asia Pacific Hospital-Acquired Disease Testing Sales by Region (2019-2024) & (K Units)
Table 41. South America Hospital-Acquired Disease Testing Sales by Country (2019-2024) & (K Units)
Table 42. Middle East and Africa Hospital-Acquired Disease Testing Sales by Region (2019-2024) & (K Units)
Table 43. Diatherix Laboratories Hospital-Acquired Disease Testing Basic Information
Table 44. Diatherix Laboratories Hospital-Acquired Disease Testing Product Overview
Table 45. Diatherix Laboratories Hospital-Acquired Disease Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 46. Diatherix Laboratories Business Overview
Table 47. Diatherix Laboratories Hospital-Acquired Disease Testing SWOT Analysis
Table 48. Diatherix Laboratories Recent Developments
Table 49. Gen-Probe Hospital-Acquired Disease Testing Basic Information
Table 50. Gen-Probe Hospital-Acquired Disease Testing Product Overview
Table 51. Gen-Probe Hospital-Acquired Disease Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 52. Gen-Probe Business Overview
Table 53. Gen-Probe Hospital-Acquired Disease Testing SWOT Analysis
Table 54. Gen-Probe Recent Developments
Table 55. Qiagen Hospital-Acquired Disease Testing Basic Information
Table 56. Qiagen Hospital-Acquired Disease Testing Product Overview
Table 57. Qiagen Hospital-Acquired Disease Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 58. Qiagen Hospital-Acquired Disease Testing SWOT Analysis
Table 59. Qiagen Business Overview
Table 60. Qiagen Recent Developments
Table 61. F. Hoffmann-La Roche Hospital-Acquired Disease Testing Basic Information
Table 62. F. Hoffmann-La Roche Hospital-Acquired Disease Testing Product Overview
Table 63. F. Hoffmann-La Roche Hospital-Acquired Disease Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 64. F. Hoffmann-La Roche Business Overview
Table 65. F. Hoffmann-La Roche Recent Developments
Table 66. Cepheid Hospital-Acquired Disease Testing Basic Information
Table 67. Cepheid Hospital-Acquired Disease Testing Product Overview
Table 68. Cepheid Hospital-Acquired Disease Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 69. Cepheid Business Overview
Table 70. Cepheid Recent Developments
Table 71. Life Technologies Corporation Hospital-Acquired Disease Testing Basic Information
Table 72. Life Technologies Corporation Hospital-Acquired Disease Testing Product Overview
Table 73. Life Technologies Corporation Hospital-Acquired Disease Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 74. Life Technologies Corporation Business Overview
Table 75. Life Technologies Corporation Recent Developments
Table 76. Meridian Biosciences Hospital-Acquired Disease Testing Basic Information
Table 77. Meridian Biosciences Hospital-Acquired Disease Testing Product Overview
Table 78. Meridian Biosciences Hospital-Acquired Disease Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 79. Meridian Biosciences Business Overview
Table 80. Meridian Biosciences Recent Developments
Table 81. Cantel Medical Corporation Hospital-Acquired Disease Testing Basic Information
Table 82. Cantel Medical Corporation Hospital-Acquired Disease Testing Product Overview
Table 83. Cantel Medical Corporation Hospital-Acquired Disease Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 84. Cantel Medical Corporation Business Overview
Table 85. Cantel Medical Corporation Recent Developments
Table 86. Nordion Hospital-Acquired Disease Testing Basic Information
Table 87. Nordion Hospital-Acquired Disease Testing Product Overview
Table 88. Nordion Hospital-Acquired Disease Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 89. Nordion Business Overview
Table 90. Nordion Recent Developments
Table 91. Global Hospital-Acquired Disease Testing Sales Forecast by Region (2025-2030) & (K Units)
Table 92. Global Hospital-Acquired Disease Testing Market Size Forecast by Region (2025-2030) & (M USD)
Table 93. North America Hospital-Acquired Disease Testing Sales Forecast by Country (2025-2030) & (K Units)
Table 94. North America Hospital-Acquired Disease Testing Market Size Forecast by Country (2025-2030) & (M USD)
Table 95. Europe Hospital-Acquired Disease Testing Sales Forecast by Country (2025-2030) & (K Units)
Table 96. Europe Hospital-Acquired Disease Testing Market Size Forecast by Country (2025-2030) & (M USD)
Table 97. Asia Pacific Hospital-Acquired Disease Testing Sales Forecast by Region (2025-2030) & (K Units)
Table 98. Asia Pacific Hospital-Acquired Disease Testing Market Size Forecast by Region (2025-2030) & (M USD)
Table 99. South America Hospital-Acquired Disease Testing Sales Forecast by Country (2025-2030) & (K Units)
Table 100. South America Hospital-Acquired Disease Testing Market Size Forecast by Country (2025-2030) & (M USD)
Table 101. Middle East and Africa Hospital-Acquired Disease Testing Consumption Forecast by Country (2025-2030) & (Units)
Table 102. Middle East and Africa Hospital-Acquired Disease Testing Market Size Forecast by Country (2025-2030) & (M USD)
Table 103. Global Hospital-Acquired Disease Testing Sales Forecast by Type (2025-2030) & (K Units)
Table 104. Global Hospital-Acquired Disease Testing Market Size Forecast by Type (2025-2030) & (M USD)
Table 105. Global Hospital-Acquired Disease Testing Price Forecast by Type (2025-2030) & (USD/Unit)
Table 106. Global Hospital-Acquired Disease Testing Sales (K Units) Forecast by Application (2025-2030)
Table 107. Global Hospital-Acquired Disease Testing Market Size Forecast by Application (2025-2030) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Hospital-Acquired Disease Testing
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Hospital-Acquired Disease Testing Market Size (M USD), 2019-2030
Figure 5. Global Hospital-Acquired Disease Testing Market Size (M USD) (2019-2030)
Figure 6. Global Hospital-Acquired Disease Testing Sales (K Units) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Hospital-Acquired Disease Testing Market Size by Country (M USD)
Figure 11. Hospital-Acquired Disease Testing Sales Share by Manufacturers in 2023
Figure 12. Global Hospital-Acquired Disease Testing Revenue Share by Manufacturers in 2023
Figure 13. Hospital-Acquired Disease Testing Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Hospital-Acquired Disease Testing Average Price (USD/Unit) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Hospital-Acquired Disease Testing Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Hospital-Acquired Disease Testing Market Share by Type
Figure 18. Sales Market Share of Hospital-Acquired Disease Testing by Type (2019-2024)
Figure 19. Sales Market Share of Hospital-Acquired Disease Testing by Type in 2023
Figure 20. Market Size Share of Hospital-Acquired Disease Testing by Type (2019-2024)
Figure 21. Market Size Market Share of Hospital-Acquired Disease Testing by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Hospital-Acquired Disease Testing Market Share by Application
Figure 24. Global Hospital-Acquired Disease Testing Sales Market Share by Application (2019-2024)
Figure 25. Global Hospital-Acquired Disease Testing Sales Market Share by Application in 2023
Figure 26. Global Hospital-Acquired Disease Testing Market Share by Application (2019-2024)
Figure 27. Global Hospital-Acquired Disease Testing Market Share by Application in 2023
Figure 28. Global Hospital-Acquired Disease Testing Sales Growth Rate by Application (2019-2024)
Figure 29. Global Hospital-Acquired Disease Testing Sales Market Share by Region (2019-2024)
Figure 30. North America Hospital-Acquired Disease Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 31. North America Hospital-Acquired Disease Testing Sales Market Share by Country in 2023
Figure 32. U.S. Hospital-Acquired Disease Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 33. Canada Hospital-Acquired Disease Testing Sales (K Units) and Growth Rate (2019-2024)
Figure 34. Mexico Hospital-Acquired Disease Testing Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Hospital-Acquired Disease Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 36. Europe Hospital-Acquired Disease Testing Sales Market Share by Country in 2023
Figure 37. Germany Hospital-Acquired Disease Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 38. France Hospital-Acquired Disease Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 39. U.K. Hospital-Acquired Disease Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 40. Italy Hospital-Acquired Disease Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 41. Russia Hospital-Acquired Disease Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 42. Asia Pacific Hospital-Acquired Disease Testing Sales and Growth Rate (K Units)
Figure 43. Asia Pacific Hospital-Acquired Disease Testing Sales Market Share by Region in 2023
Figure 44. China Hospital-Acquired Disease Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 45. Japan Hospital-Acquired Disease Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 46. South Korea Hospital-Acquired Disease Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 47. India Hospital-Acquired Disease Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 48. Southeast Asia Hospital-Acquired Disease Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 49. South America Hospital-Acquired Disease Testing Sales and Growth Rate (K Units)
Figure 50. South America Hospital-Acquired Disease Testing Sales Market Share by Country in 2023
Figure 51. Brazil Hospital-Acquired Disease Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 52. Argentina Hospital-Acquired Disease Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 53. Columbia Hospital-Acquired Disease Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 54. Middle East and Africa Hospital-Acquired Disease Testing Sales and Growth Rate (K Units)
Figure 55. Middle East and Africa Hospital-Acquired Disease Testing Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Hospital-Acquired Disease Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 57. UAE Hospital-Acquired Disease Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 58. Egypt Hospital-Acquired Disease Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 59. Nigeria Hospital-Acquired Disease Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 60. South Africa Hospital-Acquired Disease Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 61. Global Hospital-Acquired Disease Testing Sales Forecast by Volume (2019-2030) & (K Units)
Figure 62. Global Hospital-Acquired Disease Testing Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Hospital-Acquired Disease Testing Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Hospital-Acquired Disease Testing Market Share Forecast by Type (2025-2030)
Figure 65. Global Hospital-Acquired Disease Testing Sales Forecast by Application (2025-2030)
Figure 66. Global Hospital-Acquired Disease Testing Market Share Forecast by Application (2025-2030)
Figure 1. Product Picture of Hospital-Acquired Disease Testing
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Hospital-Acquired Disease Testing Market Size (M USD), 2019-2030
Figure 5. Global Hospital-Acquired Disease Testing Market Size (M USD) (2019-2030)
Figure 6. Global Hospital-Acquired Disease Testing Sales (K Units) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Hospital-Acquired Disease Testing Market Size by Country (M USD)
Figure 11. Hospital-Acquired Disease Testing Sales Share by Manufacturers in 2023
Figure 12. Global Hospital-Acquired Disease Testing Revenue Share by Manufacturers in 2023
Figure 13. Hospital-Acquired Disease Testing Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Hospital-Acquired Disease Testing Average Price (USD/Unit) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Hospital-Acquired Disease Testing Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Hospital-Acquired Disease Testing Market Share by Type
Figure 18. Sales Market Share of Hospital-Acquired Disease Testing by Type (2019-2024)
Figure 19. Sales Market Share of Hospital-Acquired Disease Testing by Type in 2023
Figure 20. Market Size Share of Hospital-Acquired Disease Testing by Type (2019-2024)
Figure 21. Market Size Market Share of Hospital-Acquired Disease Testing by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Hospital-Acquired Disease Testing Market Share by Application
Figure 24. Global Hospital-Acquired Disease Testing Sales Market Share by Application (2019-2024)
Figure 25. Global Hospital-Acquired Disease Testing Sales Market Share by Application in 2023
Figure 26. Global Hospital-Acquired Disease Testing Market Share by Application (2019-2024)
Figure 27. Global Hospital-Acquired Disease Testing Market Share by Application in 2023
Figure 28. Global Hospital-Acquired Disease Testing Sales Growth Rate by Application (2019-2024)
Figure 29. Global Hospital-Acquired Disease Testing Sales Market Share by Region (2019-2024)
Figure 30. North America Hospital-Acquired Disease Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 31. North America Hospital-Acquired Disease Testing Sales Market Share by Country in 2023
Figure 32. U.S. Hospital-Acquired Disease Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 33. Canada Hospital-Acquired Disease Testing Sales (K Units) and Growth Rate (2019-2024)
Figure 34. Mexico Hospital-Acquired Disease Testing Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Hospital-Acquired Disease Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 36. Europe Hospital-Acquired Disease Testing Sales Market Share by Country in 2023
Figure 37. Germany Hospital-Acquired Disease Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 38. France Hospital-Acquired Disease Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 39. U.K. Hospital-Acquired Disease Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 40. Italy Hospital-Acquired Disease Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 41. Russia Hospital-Acquired Disease Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 42. Asia Pacific Hospital-Acquired Disease Testing Sales and Growth Rate (K Units)
Figure 43. Asia Pacific Hospital-Acquired Disease Testing Sales Market Share by Region in 2023
Figure 44. China Hospital-Acquired Disease Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 45. Japan Hospital-Acquired Disease Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 46. South Korea Hospital-Acquired Disease Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 47. India Hospital-Acquired Disease Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 48. Southeast Asia Hospital-Acquired Disease Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 49. South America Hospital-Acquired Disease Testing Sales and Growth Rate (K Units)
Figure 50. South America Hospital-Acquired Disease Testing Sales Market Share by Country in 2023
Figure 51. Brazil Hospital-Acquired Disease Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 52. Argentina Hospital-Acquired Disease Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 53. Columbia Hospital-Acquired Disease Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 54. Middle East and Africa Hospital-Acquired Disease Testing Sales and Growth Rate (K Units)
Figure 55. Middle East and Africa Hospital-Acquired Disease Testing Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Hospital-Acquired Disease Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 57. UAE Hospital-Acquired Disease Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 58. Egypt Hospital-Acquired Disease Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 59. Nigeria Hospital-Acquired Disease Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 60. South Africa Hospital-Acquired Disease Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 61. Global Hospital-Acquired Disease Testing Sales Forecast by Volume (2019-2030) & (K Units)
Figure 62. Global Hospital-Acquired Disease Testing Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Hospital-Acquired Disease Testing Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Hospital-Acquired Disease Testing Market Share Forecast by Type (2025-2030)
Figure 65. Global Hospital-Acquired Disease Testing Sales Forecast by Application (2025-2030)
Figure 66. Global Hospital-Acquired Disease Testing Market Share Forecast by Application (2025-2030)
